Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

NAMSNAMS
7 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in NewAmsterdam Pharma Company N.V.

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 754,327 shares of NAMS (NewAmsterdam Pharma Company N.V.), worth $25.6M as of 2026-Q2. The position was increased (+4131.9% shares). NAMS represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$25.6M

Current Shares

754,327

Total Value Change

+$25.3M

Total Shares Change

+745,361

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
754,327
+4131.9%
$25.6M0.0%$33.89
46
2026-Q1
Decreased
17,825
-90.9%
$570,5780.0%$30.41
0
2025-Q4
Increased
195,635
+28.9%
$6.9M0.0%$34.74
34
2025-Q3
Increased
151,837
+69.0%
$4.3M0.0%$27.52
40
2025-Q2
Decreased
89,827
-39.7%
$1.6M0.0%$18.57
0
2025-Q1
Increased
149,036
+1562.2%
$3.1M0.0%$21.76
43
2024-Q4
New
8,966
-
$230,4260.0%$25.60
35

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used